NCT03327116View on ClinicalTrials.gov

Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

December 1, 2018

Conditions
Atopic Dermatitis
Interventions
DRUG

Methotrexate

oral, 15 mg per week, 24 weeks

Trial Locations (1)

05403900

Hospital das Clínicas of the University of São Paulo Medical School, Department of Dermatology, São Paulo

All Listed Sponsors
collaborator

FUNADERSP (Foundation for Research Support of the State of São Paulo)

UNKNOWN

lead

University of Sao Paulo General Hospital

OTHER

NCT03327116 - Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter